Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.
about
Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancerVision 20/20: Mammographic breast density and its clinical applicationsDetection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer riskComparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breastReduction of claustrophobia with short-bore versus open magnetic resonance imaging: a randomized controlled trial.The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan.Building a virtual simulation platform for quasistatic breast ultrasound elastography using open source software: A preliminary investigationNuclear imaging of the breast: translating achievements in instrumentation into clinical useHigh-field open versus short-bore magnetic resonance imaging of the spine: a randomized controlled comparison of image qualityCorrelation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scannerChallenges associated with peripheral arterial disease in women.Three-dimensional microwave imaging of realistic numerical breast phantoms via a multiple-frequency inverse scattering technique.Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imagingScreening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancerJournal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.Background parenchymal uptake during molecular breast imaging and associated clinical factors.Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel.Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.Collimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic statusIn vivo classification of breast masses using features derived from axial-strain and axial-shear images.Multiple bilateral circumscribed masses at screening breast US: consider annual follow-upInvestigating the limit of detectability of a positron emission mammography device: a phantom study.Computer-aided diagnosis of breast DCE-MRI images using bilateral asymmetry of contrast enhancement between two breasts.Patterns of breast magnetic resonance imaging use in community practiceSystematic development of an abbreviated protocol for screening breast magnetic resonance imagingThe current status of positron emission mammography in breast cancer diagnosis.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.Adjunctive Breast-Specific Gamma Imaging for Detecting Cancer in Women with Calcifications at Mammography.Utilization of breast cancer screening with magnetic resonance imaging in community practice.Comparison of mammography and ultrasonography findings with pathology results in patients with breast cancer in Birjand, Iran.The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.Informing Women and Their Physicians about Recommendations for Adjunct Breast MRI Screening: A Cohort Study.
P2860
Q28069645-DEBFFFEB-3166-4596-B397-0CBF1D86F4A4Q28081408-A1353501-52B3-4122-ACE4-4D817BA0C01DQ28263584-F2056B8C-BA0A-4DAB-93FB-E4F82BD6C425Q28305001-30157FED-3A6A-4034-979E-2981839C545AQ28741025-B62D736B-AA87-46B0-915B-0CDA5A9F4950Q30249866-A007283A-2A45-4265-8E38-7ACAEA70561FQ30375416-8E613934-393B-44C3-9D3D-8C264760F2B6Q30419180-F82790B0-EDEF-449E-94D3-76CFEC3FD7F1Q30444874-7BA83A20-E0A7-43F7-A67C-784033C4651EQ33863472-3C1CC03D-B360-4799-9467-0421D79F4EF3Q34040240-19E09C8B-79D7-4904-83F9-C677B28CC43EQ34064948-98FED9C1-FD0E-4924-9081-FC9B4C070AF1Q34420301-E44ED4DB-D2D8-42C6-8506-58FE4348B4AAQ35527940-49A17FF5-5C3D-478A-8BD7-02CCBAAD91F6Q35580579-EC62FDBF-F097-42F7-818D-A542D125B33AQ35580614-97919745-1368-414D-AAC9-C5B4453E9CBEQ35682143-7F92C5C7-46CE-42F0-A8D8-2E5457CFC3FDQ36117322-7E6CA5FA-7E05-4E2B-8683-A1D8C2701B58Q36396510-85BE0479-CE4A-44E7-95FD-4D33ED658EB2Q36510676-B8B4FFA9-3D65-4621-AC9A-4BD5D1E88387Q36547262-619CD2A3-6821-4DAD-8707-13C239F1E8ADQ36870883-3BF8BD26-CDC4-4CAD-9C4D-4A879E8695F4Q37113274-1506BDA9-9928-4B2A-8CB8-D75B2DA70332Q37489946-2D4135AC-E7B8-4CB9-BF13-5F92B41EC25DQ37522129-D3EEBDEB-7289-4D2B-8F14-1DCDD622072DQ37529123-1066BE15-090B-4543-8B98-A5C12182EFA1Q37666924-9479E132-3917-40C3-9DFE-EF4E76E32F1BQ38067336-AD6A2E53-BF82-4482-B816-B5350E5053E0Q38090509-A930217B-09AF-4CEB-A5A3-81DBC0B6E7ECQ38401557-F3A3A41A-093C-45E4-93DB-C4ED75C4F923Q38618807-B11F61C6-04FC-4ABD-96B5-0502000D8085Q46186375-43C252AA-88C4-463F-A001-B27A379F3AA1Q47129709-43A26536-6827-460A-8C7C-AA173F79C1F6Q50050762-81EE0345-7AE3-4F8B-AEA0-622455E64148Q50914124-095CD20A-2B59-4CBE-B409-635583B553A6
P2860
Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@ast
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@en
type
label
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@ast
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@en
prefLabel
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@ast
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@en
P2093
P2860
P1433
P1476
Reasons women at elevated risk ...... imaging screening: ACRIN 6666.
@en
P2093
Amanda M Adams
Daniel E Lehrer
Ellen B Mendelson
Etta D Pisano
Glenna J Gabrielli
Jeffrey D Blume
Linda Hovanessian Larsen
Mary C Mahoney
Richard G Barr
Roberta A Jong
P2860
P356
10.1148/RADIOL.2541090953
P407
P577
2010-01-01T00:00:00Z